Literature DB >> 6729138

Magnetic resonance of the brain: the optimal screening technique.

M Brant-Zawadzki, D Norman, T H Newton, W M Kelly, B Kjos, C M Mills, W Dillon, D Sobel, L E Crooks.   

Abstract

Seventy consecutive patients were examined with magnetic resonance (MR) and computed tomography (CT) of the brain. Each study was independently reviewed. Focal abnormalities were detected by one or both modalities in 51 patients. Neoplastic, infectious, vascular, demyelinating, metabolic, and congenital disorders of the brain were included. The MR pulse sequence that best detected these abnormalities was a spin-echo multisection technique that used a long interval between RF excitations (TR = 1500 or 2000 msec). Forty-eight of 51 patients showed focal lesions with this technique. A supplementary MR pulse sequence with a short TR (500 msec) was useful in helping to characterize certain lesions with a long T1 relaxation component, but in 10 of 26 positive cases in which this sequence was added it would have missed the abnormality had it been the sole sequence used. MR missed focal lesions in 3 of 51 patients. These were lesions that required thin-section (1.5 mm) CT techniques. Two were intrasellar, and one was an intracanalicular neurinoma. In 17 of 48 patients, CT missed the focal lesion seen with MR. Based on this experience, it is concluded that the long TR multisection spin-echo sequence is the optimal MR screening technique for detection of most brain abnormalities, and is more sensitive than CT. Currently, CT remains the screening modality of choice when high-resolution, thin-section studies in the pituitary, inner ear, and orbital regions are indicated.

Entities:  

Mesh:

Year:  1984        PMID: 6729138     DOI: 10.1148/radiology.152.1.6729138

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  34 in total

Review 1.  Clinical experience with MultiHance in CNS imaging.

Authors:  M Essig
Journal:  Eur Radiol       Date:  2003-11       Impact factor: 5.315

2.  Functional diffusion maps (fDMs) evaluated before and after radiochemotherapy predict progression-free and overall survival in newly diagnosed glioblastoma.

Authors:  Benjamin M Ellingson; Timothy F Cloughesy; Taryar Zaw; Albert Lai; Phioanh L Nghiemphu; Robert Harris; Shadi Lalezari; Naveed Wagle; Kourosh M Naeini; Jose Carrillo; Linda M Liau; Whitney B Pope
Journal:  Neuro Oncol       Date:  2012-01-22       Impact factor: 12.300

3.  Radiology: magnetic resonance imaging.

Authors:  C B Higgins
Journal:  West J Med       Date:  1985-09

4.  Neurosurgery: magnetic resonance imaging.

Authors:  L H Pitts
Journal:  West J Med       Date:  1986-07

5.  Magnetic resonance imaging.

Authors:  J S Fache
Journal:  Can Fam Physician       Date:  1986-05       Impact factor: 3.275

Review 6.  The brainstem and its neurosurgical history.

Authors:  A I Cucu; S Turliuc; C F Costea; A Perciaccante; R Bianucci; S Donell; D V Scripcariu; M D Turliuc
Journal:  Neurosurg Rev       Date:  2021-02-12       Impact factor: 3.042

7.  Magnetic resonance imaging for evaluating neurogenic dysphagia.

Authors:  W S Kim; D Buchholz; A J Kumar; M W Donner; A E Rosenbaum
Journal:  Dysphagia       Date:  1987       Impact factor: 3.438

8.  MRI parameters in multiple sclerosis patients.

Authors:  I Reider-Groswasser; E Kott; J Benmair; M Huberman; Y Machtey; I Gelernter
Journal:  Neuroradiology       Date:  1988       Impact factor: 2.804

9.  Exploring the frontiers of magnetic resonance imaging.

Authors:  L M Hinds
Journal:  J Natl Med Assoc       Date:  1987-01       Impact factor: 1.798

10.  Quantification of edema reduction using differential quantitative T2 (DQT2) relaxometry mapping in recurrent glioblastoma treated with bevacizumab.

Authors:  Benjamin M Ellingson; Timothy F Cloughesy; Albert Lai; Phioanh L Nghiemphu; Shadi Lalezari; Taryar Zaw; Kourosh Motevalibashinaeini; Paul S Mischel; Whitney B Pope
Journal:  J Neurooncol       Date:  2011-06-25       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.